12 completed. 12 Phase 2, 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 12 | Completed 12 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
Follow Premature Ejaculation: new trials by email Literature Review of Premature Ejaculation trials Research Report on Premature Ejaculation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| On-demand Silodosin 4mg vs Dapoxetine 60mg in Treatment of Primary Premature Ejaculation sildosin 4mg, dapoxetine 60mg - Premature (Early) Ejaculation | Phase 2 / Phase 3 | Completed | Benha University | 95 | 2024-03-01 | 2025-07-23 |
| Brain Networks Implicated in Lifelong Premature Ejaculation Patients Transcranial Radom Noise Stimulation, Take Dapoxetine, Comparation EEG changes between Sham Group against tRNS and Dapoxetin participants - Premature Ejaculation, Sexual Dysfunction | Phase 1 / Phase 2 | Completed | Moises Domingo | 128 | 2021-02-02 | 2023-04-12 |
| PSD502 in Subjects With Premature Ejaculation Placebo, PSD502 - Premature Ejaculation | Phase 2 | Completed | Plethora Solutions Ltd | 121 | 2018-12-26 | 2022-07-05 |
| Effectiveness and Tolerability of Lidocaine 5% Spray in Treatment of Lifelong Premature Ejaculation Patients. Lidocaine 5% spray, Placebo - Lidocaine Spray | Phase 2 | Completed | Sohag University | 150 | 2018-04-20 | 2019-10-07 |
| IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE) IX-01 400 mg, Placebo, IX-01 800 mg - Premature Ejaculation | Phase 2 | Completed | Ixchelsis Limited | 239 | 2017-02-28 | 2019-10-07 |
| IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE) IX-01, Placebo - Premature Ejaculation | Phase 2 | Completed | Ixchelsis Limited | 88 | 2014-09-01 | 2020-08-17 |
| Safety, Tolerability, Pharmacokinetics and Efficacy of YHD1044 dapoxetine - Premature Ejaculation | Phase 1 / Phase 2 | Completed | Yuhan Corporation | 24 | 2011-02-01 | 2012-08-01 |
| Phase 2 Trial of PED-1 and PED-2 in Male Patients With Premature Ejaculation Clomipramine - Premature Ejaculation | Phase 2 | Completed | Symyoo | 104 | 2010-09-01 | 2012-10-03 |
| A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation GSK557296, placebo - Premature Ejaculation | Phase 2 | Completed | GlaxoSmithKline | 77 | 2009-12-23 | 2017-09-12 |
| Efficacy, Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment Premature Ejaculation PSD502, contains a mixture of lidocaine and prilocaine, Placebo - Premature Ejaculation | Phase 2 / Phase 3 | Completed | Plethora Solutions Ltd | 256 | 2007-10-01 | 2016-09-26 |
| A Study On Concentrations Of 16448 In Blood And The Safety Of This Compound In Healthy Males With Premature Ejaculation 16448 - Premature Ejaculation | Phase 2 | Completed | GlaxoSmithKline | 18 | 2006-12-01 | 2012-03-19 |
| Exploratory Study of Pagoclone in Men With Premature Ejaculation. pagoclone - Premature Ejaculation | Phase 2 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 100 | 2006-07-01 | 2013-12-27 |
Sexual Dysfunction, Physiological (2) · Coitus (1) · Premature Birth (1)
Ejaculatory Dysfunction (12) · Genital Diseases (12) · Genital Diseases, Male (12) · Male Urogenital Diseases (12) · Mental Disorders (12) · Sexual Dysfunctions, Psychological (12) · Urogenital Diseases (12) · Sexual Dysfunction, Physiological (10) · Behavior (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Obstetric Labor Complications (1) · Obstetric Labor, Premature (1) · Pregnancy Complications (1) · Sexual Behavior (1)
Lidocaine, Prilocaine Drug Combination (2) · dapoxetine (2) · Clomipramine (1) · Lidocaine (1) · MG 50-3-1 (1) · Prilocaine (1) · epelsiban (1) · pagoclone (1)
GlaxoSmithKline (2) · Ixchelsis Limited (2) · Plethora Solutions Ltd (2) · Benha University (1) · Endo USA Inc., a Keenova Therapeutics Company (1) · Moises Domingo (1) · Sohag University (1) · Symyoo (1) · Yuhan Corporation (1)
United States (6) · Egypt (2) · South Korea (2) · Australia (1) · Ireland (1) · Netherlands (1) · Spain (1)
Alejandro Molina Cabeza, MD (1) · Culley Carson, MD (1) · Jed Kaminetsky, MD, BA (1) · Whan-Seok Choi, MD, PhD (1)